Sirona Biochem completes $635K private placement

News Release

Sirona Biochem Announces Close of Oversubscribed Private Placement

Vancouver, British Columbia – October 26, 2017 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (Xetra: ZSB) (the “Company”) announced today that it has closed an oversubscribed, non-brokered private placement for gross proceeds of $635,000. The private placement consists of 4,233,333 units, (the “Units”) at a price of $0.15 per Unit. Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.25 per share.
Dr. Howard Verrico, CEO, has participated in the Private Placement with the purchase of 1,000,000 Units and upon completion, owns 5,951,250 common shares.

All securities issued under the placement are subject to statutory hold periods expiring on February 26, 2018.

Proceeds of the placement will be used for general working capital.

About Sirona Biochem Corp.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information please visit www.sironabiochem.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information regarding this press release, please contact:
Christopher Hopton, CFO Sirona Biochem Corp. Phone: 1.604.282.6064 Email: chopton@sironabiochem.com